dermatology clinics

Abstract: Androgenetic alopecia (AGA) is characterized by patterned follicular miniaturization, increased single-hair follicular units, and altered hair-shaft diameter. We present an automated quantitative scalp-analysis and clinical decision-support framework combining FU localization, ordinal visible-shaft counting, calibrated shaft-width estimation, regional aggregation, and an interpretable rule layer. The clinical cohort comprised 243 patients (127 AGA, 116 non-AGA), while the computer-vision experiments used 160 expert-annotated patients, 2,400 trichoscopic images, and approximately 158,000 FU annotations. Under patientdisjoint evaluation, YOLOv8m achieved test mAP@0.5=0.920 and recall=0.860; EfficientNet-B5 with a support-map channel achieved 87.0% expert-box count accuracy (macro F1=0.85). A separate 500-image set was processed end-to-end with detector-generated boxes, yielding MAE of 6.56 for follicle detection and 16.59 for follicle classification relative to human-expert annotations. The system is intended to assist, rather than replace, dermatologist interpretation.

Abstract: Mycosis fungoides (MF) is a rare form of cutaneous T-cell lymphoma that is often misdiagnosed in early stages due to its visual similarity to benign inflammatory dermatoses. Early and accurate diagnosis is critical for improving patient outcomes. In this paper, we propose a comprehensive diagnostic framework for automated MF detection that combines dual- scale histopathological image analysis with deep learning. To distinguish MF from other lymphoproliferative skin conditions, the proposed approach leverages a late-fusion ensemble of dual- magnification (10x and 20x) convolutional neural networks (CNNs), complemented by a random forest classifier trained on 16 clinical features. Experimental results on an expanded dataset of 6,267 images (4,306 MF; 1,961 Non-MF) across 463 patients demonstrate that strong detection performance is obtained by prioritizing higher-resolution cytological details (20x) within broader architectural context (10x). The image-based late-fusion model achieves an accuracy of 83.58% and a sensitivity of 89.13%, while the clinical random forest model achieves an accuracy of 96.6% and sensitivity of 93.8%, highlighting the po- tential of this multimodal framework as a robust clinical decision support system in dermatology. This framework addresses two distinct clinical objectives: an image-based dual-scale pipeline optimized for the early diagnostic screening of MF versus non- MF dermatoses, and a complementary clinical metadata model designed for the subsequent staging of confirmed MF cases (patch/plaque versus tumor)

Abstract: Acne assessment is crucial for clinical decision-making, yet traditional grading and counting are subjective and fail to account for lesion size. While area-based assessment has emerged as a promising alternative, acne segmentation has continued to rely on general-purpose architectures. To address this gap, we propose VL-AcneSeg, a multimodal framework for acne lesion segmentation that leverages CLIP and region-level text prompts to incorporate spatial priors, enabling lesions to be localized across the whole face. Because region-level prompts indicate which facial areas contain lesions, we report a single global prompt, which requires no such information, as our primary setting. On our internal clinical dataset, VL-AcneSeg achieves a Dice score of 0.5082 and an IoU of 0.3407 under this protocol, the highest among all compared methods, including recent vision-language segmentation methods that are themselves given region-level prompts; region-level prompting raises these to 0.5296 and 0.3602. Moreover, lesion area measurements derived from our segmentation correlate with IGA scores at a level comparable to expert annotations (Pearson r = 0.719 versus 0.658). Notably, our framework maintains consistent performance across external validation datasets, performing reliably even on uncontrolled smartphone images without requiring additional training or fine-tuning. By pairing a protocol that requires no lesion-location information with area-based severity estimation, this work provides a foundation for objective acne assessment outside the clinic. Our implementation is publicly available at: https://github.com/sukjuoh/VL-AcneSeg

Abstract: Artificial intelligence (AI) has advanced at a rapid pace in recent years. Initially, breakthroughs in large language models caught widespread attention. However, recent generations of frontier AI models have adopted multimodal capabilities as a first class citizen, with vision capabilities being central to that. In this paper, we evaluate three recently released models on the task of diagnosing dermatological conditions from patient-submitted images. The models chosen are at the low to mid tier in terms of pricing and thus represent a floor on current AI capabilities, not a ceiling. We evaluate AI performance relative to a panel of three certified dermatologists, who grade each image, and we present four interesting findings. Firstly, depending on the metric, the tested AI models are either on par or slightly trail humans in terms of inter-clinician agreement. Secondly, we find that asking AI models for a confidence rating produces poorly calibrated answers, meaning use of confidence thresholds should not be relied upon in a clinical setting. Thirdly, the effect of providing additional patient metadata is strongly model-specific, with one of the three models degrading on every metric considered. Finally, model cost is not predictive of performance. The best-performing model we tested costs on average $0.0045 per case.

Abstract: Early diagnosis of melanoma is critical for improving patient survival rates. However, accurately distinguishing melanoma from other skin lesions remains a significant clinical challenge due to the high visual similarity among lesion types and variability in image acquisition conditions. Artificial intelligence, particularly machine learning, has emerged as a promising tool to support dermatological diagnosis by automating feature extraction from medical images. Among the available approaches, convolutional neural networks (CNNs) have demonstrated strong performance in image classification tasks, making them well-suited for analyzing both dermatoscopic and histopathological images, given their ability to capture hierarchical visual patterns relevant to lesion characterization. Nevertheless, despite numerous pre-trained CNN architectures having been proposed, selecting the most appropriate one for a given imaging modality remains an open challenge. In this study, we evaluate pre-trained convolutional neural networks (CNNs) for skin lesion classification using dermatoscopic and histopathological image datasets. Experiments were conducted on the HAM10000, ISIC 2018, and CR-AI4SkIN datasets, evaluating the ResNet50, VGG16, VGG19, MobileNet, and InceptionV3 architectures under the same training protocol. The experimental evaluation showed that the models achieved accuracies ranging from 71% (InceptionV3 on ISIC 2018) to 84% (ResNet50 on HAM10000) on dermatoscopic images. For histopathological images, accuracies ranged from 72% (VGG19) to 83% (ResNet50) on the CR-AI4SkIN dataset. The results demonstrate that model performance differs between dermatoscopic and histopathological image modalities, showing that architectures exhibiting similar performance on dermatoscopic images exhibit different performance on histopathological data.

Abstract: This paper outlines the specifications and design approach used to construct a full body imaging scanner capable of capturing skin lesions at a dermatoscopic level using cameras mounted on the end-effectors of four UR10 manipulators. The system possesses a view-planning algorithm capable of appropriately selecting the best camera position to acquire images of moles, a high-level controller to allow the manipulators to work simultaneously and a collision-detector that halts the manipulators when they make contact with an object or a person. We evaluate the system through real-patient full-body scans, comparing acquired images against contact dermoscopy and an existing total-body photography system (Vectra) across clinically relevant lesion features, and quantify true optical resolving power using a USAF 1951 resolution target, yielding a smallest resolvable feature size of 22.1 microns for our scanner compared to 8.8 microns for contact dermoscopy. Results show the scanner consistently outperforms Vectra across most clinically relevant features and achieves comparable performance to contact dermoscopy for the majority of features assessed. By acquiring dermatoscopic-quality images automatically and without contact, and without requiring a separate manual dermoscopic examination, the scanner closes part of the gap between total-body photography and handheld dermoscopy, suggesting potential for future integration into screening workflows.

Abstract: Basal Cell Carcinoma (BCC) is the most common type of skin cancer, accounting for nearly 80% of skin cancer di- agnoses. Its optimal clinical management is guided by the distinct histopathologic subtype, with aggressive variants requiring more drastic measures. In current clinical practice, subtyping relies on skin biopsies, a procedure both costly and invasive. In this paper, we conduct a preliminary investigation into using deep learning for BCC subtyping, solely from a single dermatoscopic image of the lesion. Given the limited data at our disposal, we employ pre-trained vision transformers (ViTs), a state-of-the-art family of models highly effective for challenging downstream tasks with limited labeled data. Through repeated stratified k-fold cross-validation, we demonstrate that ViTs can achieve superior performance (AUC 0.784 on a dataset of 1271 dermatoscopic images of various BCC subtypes) over standard CNN-based baselines as well as previously-reported human reader perfor- mance, on the task of differentiating aggressive BCCs from other subtype families. These initial findings highlight the potential of combining deep learning and dermatoscopy to provide a biopsy- free alternative for BCC subtyping, thus aiding in improving treatment planning and patient outcomes.